Champions Oncology, Inc.

US$4.79As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CSBRHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 11.70%
Div yield —
ROE (28.38%)
Biotechnology
Beta (5Y) 0.45
PE TTM —
TSR TTM (29.97%)
Mkt cap US$66.67M
ROIC (12.53%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$4.68
(2.35%)
(89.36%)
Sell 2|3|6|10|12
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.08
0.09
0.10
0.10
16.27%
11.34%
26.72%
19.19%
Revenue$M
5.407
5.263
5.121
5.110
3.58%
3.67%
0.32%
(4.37%)
Peers (US$66.67M)
Cap (US$)
PE
67.46M
—
Capital
TTM
5Y
10Y
Leveragex
0.725
(0.220)
(0.207)
EBIT/Intx
2.050
0.331
0.323
Own earn%
230.41
(93.22)
(64.09)
Sh yield%
14.88
35.36
35.16
Owners
Insiders/Inst%
7.65
69.04
Short interest%
5.39
SBC / revenue%
4.09
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
11–16
$1 testx
—
Incr. ROIC%
12